Coronado Biosciences Receives $25,784,568 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b58b9d56-ca69-4c03-80d6-8975d49c2e9c&Preview=1 -
Date
7/6/2011 -
Company Name
Coronado Biosciences -
Mailing Address
45 Rockefeller Plaza New York, NY 10111 -
Company Description
Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes. -
Website
http://www.CoronadoBioSciences.com -
Transaction Type
Venture Equity -
Transaction Amount
$25,784,568 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
